Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q44453472

about

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration Left ventricular function in treatment-naive early rheumatoid arthritis.Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment Cardiovascular involvement in autoimmune diseases.Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis Cardiovascular co-morbidity in patients with rheumatic diseases.Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.Is preclinical autoimmunity benign?: The case of cardiovascular disease.Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile?Cardiovascular disease is preventable among women.Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Cardiovascular safety of biologic therapies for the treatment of RA.Biomarkers of rheumatoid arthritis: recent progress.Novel risk factors for cardiovascular disease in rheumatoid arthritis.Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.Biomarkers for cardiovascular risk assessment in autoimmune diseases.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Atherosclerotic vascular disease in the autoimmune rheumatologic patient.High titer of anti-citrullinated peptide antibody is a risk factor for severe carotid atherosclerotic plaque in patients with rheumatoid arthritis: the TOMORROW study.Cardiovascular risk in patients with rheumatoid arthritis.Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis.Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population.Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

P2860

Q30885473-53E716E9-0290-43C1-A909-317AFC439360 Q33847043-CE65ABC9-7DD9-439A-88EC-EA1096B58A68 Q33865776-685352B4-0CFC-48B2-84B3-C6363FD954CF Q33943374-8AAB7882-6C29-4AA6-895E-5ABAAC72FB4B Q34081242-4AD62DEB-4DE8-48E5-8E34-25EF051C1786 Q34482096-840D882A-EAFD-4D9E-BF0A-6F42F309CFAB Q35035496-FC4656D9-53C6-4ED6-97DF-63CA04E97339 Q35151573-44C7050E-5714-408B-8186-3ECC3910C054 Q35152141-1B9A1D70-1AF1-49C9-A57B-BB91311045F7 Q35557796-69A49F46-1D38-4935-81F3-FE539177D99E Q35617716-AE193F5A-16C8-4903-9CD8-16C703F12359 Q35994186-F0AE7A06-7064-4DCE-80F6-AAFA5ADAED9A Q36001551-9CD9DD33-3D31-49F7-A1C3-A640266402B1 Q36098311-6C6AEDEF-B3DB-423E-B6A4-926B0FAF6D6B Q36490766-A7D287E8-827D-4401-A82A-44A9E82C26D5 Q36737988-757C04B5-C9B8-4E7E-BB5C-7A67535ED58A Q36812587-5CA81B43-8F07-468F-A06B-4CB9DF1E2B10 Q36932166-A29BD2A6-0228-41F0-9051-6AB9B27DB325 Q37163146-E3CCE988-CB06-48F4-858D-F1F438E3E53F Q37688153-49C3D7F7-B7AA-44AE-A423-22E2D1388139 Q37690048-E3CDE375-1DC9-40FC-83C0-8304DC7E7CC4 Q37710782-7E0C9543-1974-4D0E-86E1-7A4435BCCDF0 Q37883018-782D21F3-9CE6-402E-B72A-8DB128833794 Q37956137-4FB44E18-9650-4E58-98CE-13D4B3C36F8A Q38089869-0540F0D7-C774-4EA9-BC15-B9CC25FD162F Q38098935-FF7B437A-A855-4FE2-87BE-A934F6B1ED08 Q38260198-A582652C-53F7-4C38-8BEF-67BEF0C72969 Q38293735-E102C4B9-D55A-4D6D-9E64-3906B061B255 Q38335622-BC2417E2-27E5-4BCF-A01F-431D21D122C0 Q38365624-886D2BB5-84DC-4783-98C0-F1A63B5F19E7 Q38719851-7B85182F-1FA0-4A88-8F5E-79B5FDD77916 Q38813397-56DB3BFC-78CD-48C6-9585-01437C18D865 Q38857820-81A2FE04-7B90-4770-AD1F-365BDA5CAF09 Q39078542-1155E6CF-7E39-43FF-B184-2158C9AA8F11 Q39783377-B6A0A8DC-4D0A-42EB-B1A8-6B0044514927 Q39920872-692C3DC4-EC85-4F44-B1A1-050C45DDAE25 Q40117130-56004662-DA57-47D0-BA4C-530A25D8C8AB Q41617609-D40A2B93-F994-4FB4-895C-9CD05B60806D Q43450932-A139A955-67E6-4550-811C-0EE816FDA5EA Q43832641-3DCD5A89-9C3B-4F4B-8656-55CAF935CF91

P2860

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q44453472

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Association between anti-cycli ...... nts with rheumatoid arthritis.

@en

Association between anti-cycli ...... nts with rheumatoid arthritis.

@nl

type

label

Association between anti-cycli ...... nts with rheumatoid arthritis.

@en

Association between anti-cycli ...... nts with rheumatoid arthritis.

@nl

prefLabel

Association between anti-cycli ...... nts with rheumatoid arthritis.

@en

Association between anti-cycli ...... nts with rheumatoid arthritis.

@nl

P1433

Q44453472-A5CD48B8-DF47-4C8C-B126-7CEE2D80F139

P1476

Q44453472-E34CC0F8-6604-409A-88E1-264548FA24AB

P2093

Q44453472-10BBD693-EEB8-4831-A172-0781DCC2D993

Q44453472-20E6E94E-296C-4D6D-A036-4DAEC32A9075

Q44453472-71979B01-1B18-491D-84E4-2C222D15E577

Q44453472-83175525-455D-4CEB-839F-4F8DE6C8F690

Q44453472-8879E444-D98E-4DB5-9BE0-3A47EEC1BFCB

Q44453472-8E9431C8-DDDC-48F4-BFE4-F578719FFD52

Q44453472-9501B56A-A5CB-4006-9DE2-74A3BE505053

Q44453472-9F3A601E-977C-45B0-9ED1-E0C4876BCE8E

Q44453472-AE6E78B7-EA84-49AE-A452-A9C0EF297458

Q44453472-D761C272-7285-4269-A9AB-0C10766499A3

P304

Q44453472-91E8FCA5-D8EB-4047-8ED7-1B594E7288C4

P31

Q44453472-331A6452-6A3F-4D8B-BC38-3503885A3F62

P356

Q44453472-A089BBAD-B284-41A4-9C39-343335A9A820

P433

Q44453472-F6EE35A2-7DCF-4777-9EC2-ABE419C46D58

P478

Q44453472-24012E89-7FA6-4AE4-BCD5-F5C0A9F20AE0

P577

Q44453472-E3A58EF6-31BF-44F3-9C70-675560196461

P5875

Q44453472-3B44F343-2C0A-4B98-8F45-A03648D4611F

P698

Q44453472-22ABB1AE-8C66-4410-BC99-5DF7ADD917BD

P921

Q44453472-4C80388B-B360-4D4C-8198-D525680E80BC

Q44453472-8B841882-ACFA-431A-B6AE-3331283CB27C

P356

P1433

Arthritis & Rheumatology

P1476

Association between anti-cycli ...... nts with rheumatoid arthritis.

@en

P2093

Alexandra Paravisini

http://www.w3.org/2001/XMLSchema#string

Carlos-Manuel González

http://www.w3.org/2001/XMLSchema#string

Desamparados Oliver-Miñarro

http://www.w3.org/2001/XMLSchema#string

Eugenia González-Díaz de Rábago

http://www.w3.org/2001/XMLSchema#string

Francisco Javier López-Longo

http://www.w3.org/2001/XMLSchema#string

Indalecio Monteagudo

http://www.w3.org/2001/XMLSchema#string

Inmaculada de la Torre

http://www.w3.org/2001/XMLSchema#string

Luis Carreño

http://www.w3.org/2001/XMLSchema#string

Margarita Rodríguez-Mahou

http://www.w3.org/2001/XMLSchema#string

Marta García-Castro

http://www.w3.org/2001/XMLSchema#string

P304

419-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.24390

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24246239

http://www.w3.org/2001/XMLSchema#string

P698

19333979

http://www.w3.org/2001/XMLSchema#string

P921